These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33291737)

  • 21. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
    Ben Simon GJ; Bakalash S; Aloni E; Rosner M
    Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues.
    Crooke A; Colligris B; Pintor J
    Curr Med Chem; 2012; 19(21):3508-22. PubMed ID: 22709004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.
    Wheeler LA; Gil DW; WoldeMussie E
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S290-4; discussion S295-6. PubMed ID: 11377451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina.
    Goto W; Ota T; Morikawa N; Otori Y; Hara H; Kawazu K; Miyawaki N; Tano Y
    Brain Res; 2002 Dec; 958(1):10-9. PubMed ID: 12468025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.
    Prokosch V; Schallenberg M; Thanos S
    PLoS One; 2013; 8(2):e49730. PubMed ID: 23468831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.
    Chen MJ; Chou JC; Hsu WM; Liu JH
    J Chin Med Assoc; 2003 May; 66(5):276-81. PubMed ID: 12908569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma.
    Zhang Y; Wu N; Li Q; Hu X; Wang L; Sun JG; Wang Z; Sun XH
    Exp Eye Res; 2021 Mar; 204():108449. PubMed ID: 33465395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury.
    Russo R; Adornetto A; Cavaliere F; Varano GP; Rusciano D; Morrone LA; Corasaniti MT; Bagetta G; Nucci C
    Mol Vis; 2015; 21():718-29. PubMed ID: 26167113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
    Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
    Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.
    Cho SW; Kim JM; Park KH; Choi CY
    Jpn J Ophthalmol; 2010 Sep; 54(5):407-13. PubMed ID: 21052902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol Delays Retinal Ganglion Cell Loss and Attenuates Gliosis-Related Inflammation From Ischemia-Reperfusion Injury.
    Luo H; Zhuang J; Hu P; Ye W; Chen S; Pang Y; Li N; Deng C; Zhang X
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3879-3888. PubMed ID: 30073348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway.
    Li Q; Cheng Y; Zhang S; Sun X; Wu J
    J Neuroinflammation; 2021 Nov; 18(1):271. PubMed ID: 34789280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of beta-adrenergic antagonists.
    Chen YN; Yamada H; Mao W; Matsuyama S; Aihara M; Araie M
    Brain Res; 2007 May; 1148():28-37. PubMed ID: 17368577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
    Frampton JE
    Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.